Connection
Jay Portnoy to Vaccines
This is a "connection" page, showing publications Jay Portnoy has written about Vaccines.
|
|
Connection Strength |
|
 |
|
 |
|
0.285 |
|
|
|
-
Kelso JM, Greenhawt MJ, Li JT, Nicklas RA, Bernstein DI, Blessing-Moore J, Cox L, Khan D, Lang DM, Oppenheimer J, Portnoy JM, Randolph CR, Schuller DE, Spector SL, Tilles SA, Wallace D. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012 Jul; 130(1):25-43.
Score: 0.102
-
Kelso JM, Li JT, Nicklas RA, Blessing-Moore J, Cox L, Lang DM, Oppenheimer J, Portnoy JM, Randolph C, Schuller DE, Spector SL, Tilles S, Wallace D, Ballas ZK, Baker JR, Bellanti JA, Ein D, Grammer LC. Adverse reactions to vaccines. Ann Allergy Asthma Immunol. 2009 Oct; 103(4 Suppl 2):S1-14.
Score: 0.085
-
Esch RE, Portnoy J. Allergen immunotherapy. Curr Allergy Asthma Rep. 2001 Nov; 1(6):491-7.
Score: 0.049
-
Portnoy JM. Immunotherapy for allergic diseases. Clin Rev Allergy Immunol. 2001 Oct; 21(2-3):241-59.
Score: 0.049
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|